| 10119-6 |
ST wave displacement.mid.lead AVL |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST wave mid displacement in lead AVL |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10119-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST wave MD L-AVL |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave MD L-AVL; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101190-7 |
5F-MDMB-PICA |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
5F-MDMB-PICA [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
101190-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
5F-MDMB-PICA Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.75 |
2.74 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 101191-5 |
5F-MDMB-PICA/Creatinine |
MRto |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
5F-MDMB-PICA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mg creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
101191-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
5F-MDMB-PICA/Creat Ur Cfm |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.75 |
2.74 |
|
|
|
|
|
|
|
ng/mg{creat} |
|
|
|
0 |
| 101192-3 |
5F-MDMB-PICA |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
5F-MDMB-PICA [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
101192-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
5F-MDMB-PICA Ur Ql Cfm |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101193-1 |
Sphincter excision plane |
Anat |
Colorectal cancer specimen |
Pt |
Nom |
|
|
ACTIVE |
Sphincter excision plane [Anatomy] in Colorectal cancer specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
101193-1 |
|
|
|
|
Observation |
|
|
|
0 |
Sphincter excision plane CRC spec |
|
|
|
N |
|
Anatomy; CA; Ca spec; CRC spec; Nominal; Pathology; Point in time; Random; Spec |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101194-9 |
Mesocolic excision plane |
Anat |
Colorectal cancer specimen |
Pt |
Nom |
|
|
ACTIVE |
Mesocolic excision plane [Anatomy] in Colorectal cancer specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
101194-9 |
|
|
|
|
Observation |
|
|
|
0 |
Mesocolic excision plane CRC spec |
|
|
|
N |
|
Anatomy; CA; Ca spec; CRC spec; Nominal; Pathology; Point in time; Random; Spec |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101195-6 |
Depth of invasion beyond muscularis propria |
Len |
Colorectal cancer specimen |
Pt |
Qn |
|
|
ACTIVE |
Depth of invasion beyond muscularis propria [Length] in Colorectal cancer specimen |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
PATH |
|
101195-6 |
|
|
|
|
Observation |
|
|
|
0 |
Dpt invasion muscularis propria CRC spec |
|
|
|
N |
|
CA; Ca spec; CRC spec; Dpt invasion muscularis propria; Dpth; Length; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec |
2.75 |
2.74 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
| 101196-4 |
Inflammatory cell infiltrate |
Find |
Colorectal cancer specimen |
Pt |
Nom |
|
|
ACTIVE |
Inflammatory cell infiltrate in Colorectal cancer specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
101196-4 |
|
|
|
|
Observation |
|
|
|
0 |
Inflammatory cell infiltrate CRC spec |
|
|
|
N |
|
CA; Ca spec; CRC spec; Finding; Findings; Nominal; Pathology; Point in time; Random; Spec |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101197-2 |
Lymph nodes with metastasis/Lymph nodes examined |
NFr |
Colorectal cancer specimen |
Pt |
Qn |
|
|
ACTIVE |
Lymph nodes with metastasis/Lymph nodes examined in Colorectal cancer specimen |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
PATH |
|
101197-2 |
|
|
|
|
Observation |
|
|
|
0 |
LN met/LN exam NFr CRC spec |
|
|
|
N |
|
CA; Ca spec; CRC spec; LN exam; LN met; LN met/LN exam; Metastases; Mets; Number fraction; PATHOLOGY; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec |
2.75 |
2.74 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 101198-0 |
Albumin |
MCnc |
Ser/Plas |
Pt |
Qn |
Nephelometry |
|
ACTIVE |
Albumin [Mass/volume] in Serum or Plasma by Nephelometry |
|
MIN |
DefinitionDescription |
|
|
g/L;g/dL |
|
|
|
|
|
|
CHEM |
|
101198-0 |
|
Nephelometry |
|
|
Both |
|
|
|
0 |
Albumin SerPl Neph-mCnc |
|
|
|
N |
|
Alb; Chemistry; Level; Light scattering; Mass concentration; Nephelom; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
mg/dL;mg/L |
|
|
|
0 |
| 101199-8 |
Protein.monoclonal band 5/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 5/Protein.total in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
N/A |
|
|
|
CHEM |
|
101199-8 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 5 MFr SerPl Elph |
|
|
|
N |
|
Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; M Protein; M Protein 5; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.75 |
2.74 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 1012-4 |
E super little w Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
E sup(w) Ab [Presence] in Serum or Plasma |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1012-4 |
|
|
|
|
Observation |
|
|
|
0 |
E sup(w) Ab SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; E sup(w); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.63 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Added 'super' to indicate the 'w' is a superscript to the E antigen. |
0 |
| 10120-4 |
ST wave displacement.mid.lead AVR |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST wave mid displacement in lead AVR |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10120-4 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST wave MD L-AVR |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave MD L-AVR; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101200-4 |
Protein.monoclonal band 6/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 6/Protein.total in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
N/A |
|
|
|
CHEM |
|
101200-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 6 MFr SerPl Elph |
|
|
|
N |
|
Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; M Protein; M Protein 6; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.75 |
2.74 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 101201-2 |
Measles virus Ab.IgG index |
ACnc |
Ser+CSF |
Pt |
Qn |
|
|
ACTIVE |
Measles virus IgG Ab index [Units/volume] in Serum and CSF |
|
MIN |
DefinitionDescription |
|
|
index value |
|
|
|
|
|
|
MICRO |
|
101201-2 |
|
|
|
|
Observation |
|
|
|
0 |
MeV IgG Index Ser+CSF-aCnc |
|
|
|
N |
|
ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Immune globulin G; Immunoglobulin G; MeV; Microbiology; Msls; Point in time; QNT; Quan; Quant; Quantitative; Random; Rubeola; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 101202-0 |
Mumps virus Ab.IgG index |
ACnc |
Ser+CSF |
Pt |
Qn |
|
|
ACTIVE |
Mumps virus IgG Ab index [Units/volume] in Serum and CSF |
|
MIN |
DefinitionDescription |
|
|
index value |
|
|
|
|
|
|
MICRO |
|
101202-0 |
|
|
|
|
Observation |
|
|
|
0 |
MuV IgG Index Ser+CSF-aCnc |
|
|
|
N |
|
ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Immune globulin G; Immunoglobulin G; Microbiology; MuV; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 101203-8 |
Herpes simplex virus 1+2 Ab.IgG index |
ACnc |
Ser+CSF |
Pt |
Qn |
|
|
ACTIVE |
Herpes simplex virus 1+2 IgG Ab index [Units/volume] in Serum and CSF |
|
MIN |
DefinitionDescription |
|
|
index value |
|
|
|
|
|
|
MICRO |
|
101203-8 |
|
|
|
|
Observation |
|
|
|
0 |
HSV1+2 IgG Index Ser+CSF-aCnc |
|
|
|
N |
|
ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV1; HSV1+2; i; II; Immune globulin G; Immunoglobulin G; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 101204-6 |
Varicella zoster virus Ab.IgA |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Varicella zoster virus IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
index value |
|
|
|
|
|
|
MICRO |
|
101204-6 |
|
IA |
|
|
Both |
|
|
|
0 |
VZV IgA SerPl IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; Immune globulin A; Immunoglobulin A; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Shingles; SR; SUDS; VZ; VZV; Zoster |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 101205-3 |
Plasmodium sp Ab.IgG |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Plasmodium sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
index value |
|
|
|
|
|
|
MICRO |
|
101205-3 |
|
IA |
|
|
Both |
|
|
|
0 |
Plasmodium IgG SerPl IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; Malaria; Malarial; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 101206-1 |
Dengue virus NS1 Ag |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Dengue virus NS1 Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
index value |
|
|
|
|
|
|
MICRO |
|
101206-1 |
|
IA |
|
|
Both |
|
|
|
0 |
DENV NS1 Ag SerPl IA-aCnc |
|
|
|
N |
|
Antigen; Antigens; Arbitrary concentration; Breakbone fever; Dengue fever; Denv; DENV NS1; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; IAA; MEIA; Microbiology; NS1; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 101207-9 |
Hepatitis E virus Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hepatitis E virus IgG Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101207-9 |
|
Line blot |
|
|
Both |
|
|
|
0 |
HEV IgG SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hep; Hep E; Hepatis; Hepatit; HEV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101208-7 |
Hepatitis E virus Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101208-7 |
|
Line blot |
|
|
Both |
|
|
|
0 |
HEV IgM SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hep; Hep E; Hepatis; Hepatit; HEV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101209-5 |
Hantavirus Ab.IgG panel |
- |
Ser/Plas |
Pt |
- |
Line blot |
|
ACTIVE |
Hantavirus IgG panel - Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
101209-5 |
|
Line blot |
|
|
Order |
|
|
|
0 |
Hantavirus IgG panel SerPl Line blot |
|
|
|
N |
|
Hanta virus; Hantavirus IgG panel; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin G; Immunoglobulin G; Microbiology; Orthohantavirus; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 10121-2 |
ST wave displacement.mid.lead I |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST wave mid displacement in lead I |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10121-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST wave MD L-I |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave MD L-I; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101210-3 |
Hantavirus puumala Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101210-3 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
PUUV IgG SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; PUUV; Ql; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |